Biotech is set to push new frontiers in precision oncology therapeutics

Cancer, the second leading cause of death, has been recognised as a global health risk, with an estimated 19.3 million new cases in 2020. Asia accounts for half of the world’s cancer burden, with nearly 49.3 per cent of new cases and 58.3 per cent of cancer deaths (2020). Moreover, estimates show its incidence may […] The post Biotech is set to push new frontiers in precision oncology therapeutics appeared first on e27.